FDA Approved: LACTULOSE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

The FDA approved a supplemental application for lactulose from PAI Holdings (PAI Pharma), updating its labeling and potentially expanding the approved uses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)

Snippet

SUPPL AP for LACTULOSE (LACTULOSE)